Phenylephrine Products Proliferate Due To Pseudoephedrine Restrictions
This article was originally published in The Tan Sheet
The growing trend of limiting pseudoephedrine accessibility in stores is driving an expanding market for nasal decongestant alternatives containing phenylephrine
You may also be interested in...
Reformulating pseudoephedrine products has posed a greater challenge than expected for a number of firms, as passage of a federal bill restricting sale of the ingredient looms
Perrigo's fiscal 2006 pseudoephedrine sales will decrease 35% to the $110 mil. to $120 mil. range, the company projected during a 2005 year-end and fourth quarter analysts call Sept. 7
Cough/cold medications reformulated to exclude pseudoephedrine would receive expedited review by FDA under a provision included in a recent draft of the Combat Meth Act